CI

At a glance

ClinicalIndex Comparison Record
Phase 3Recruiting· 426 target
Drug / intervention
Whole body hypothermia +3 moreprocedure
Likely dose
Not stated in record
Key inclusion· 8
  • Born at or after 36 weeks gestation
  • Birth weight 1800g or more
  • Birth acidosis or requiring resuscitation at birth
  • Apgar score <6 at 10 minutes OR continued resuscitation at 10 minutes OR severe birth acidosis (pH ≤7.00 or Base deficit ≥16mmol/l)
Key exclusion· 5
  • Meet BAPM criteria for whole-body hypothermia
  • Less than two abnormalities on structured neurological examination (no encephalopathy)
  • Major congenital or chromosomal anomalies identified prior to randomisation
  • Birthweight <1800g

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05889507
NCT05889507Phase 3RecruitingHigh MomentumUpdated 4mo ago

Whole-body Hypothermia Versus Normothermia in Mild Neonatal Encephalopathy: A Multicentre Randomised Controlled Trial

Imperial College London·interventional·Posted Jun 5, 2023·Updated Feb 6, 2026

In Brief

A Phase 3 clinical trial evaluating Whole body hypothermia, Targeted normothermia, and 2 other interventions for Neonatal Encephalopathy and Newborn Asphyxia. Currently recruiting, targeting 426 participants across 39 sites in 2 countries.

Signals

Enrolling ahead of pace

Detailed Summary

The goal of this randomised control trial is to establish the safety and efficacy of whole-body hypothermia for babies with mild hypoxic ischaemic encephalopathy, inform national and international guidelines, and establish uniform practice across the NHS. The main questions it aims to answer are: 1. Does whole-body cooling (33.5±0.5°C) initiated within six hours of birth and continued for 72 hours, improve cognitive development at 24 (±2) months of age after mild neonatal encephalopathy compared with normothermia (37±0.5°C)? 2. Does a prospective trial-based economic evaluation support the provision of cooling therapy for mild encephalopathy in the NHS on cost-effectiveness grounds? Participants will have the following interventions: * Randomisation into one of the following groups * Whole body hypothermia group * Targeted normothermia group * Bayley Scales of Infant and Toddler Development 4th Edition (Bayley-IV) examination at 24 (±2) months of age. Researchers will compare the mean Cognitive Composite Scale score from the Bayley IV examination between the two groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesItaly, United Kingdom
Collaborators--

Timeline

Phase 3Recruiting
2024202520262027202820292030
First PostedJun 5, 2023
Enrollment StartMar 15, 2024
Primary CompletionJan 1, 2030
TodayJul 1, 2026
Enrollment to primary: 5.8 yearsPosted 3.1 years agoPrimary completion in 3.5 years

Interventions

Whole body hypothermiaprocedure

Whole-body hypothermia (33.5±0.5°C) initiated within 6 hours of birth and continued for 72 hours. The rectal temperature will be maintained at 33.5±0.5°C using a servo-controlled cooling machine.

Targeted normothermiaprocedure

The axillary temperature will be maintained at 37±0.5°C for the first 80 hours and any hyperthermia will be treated with a standardised protocol.

Supportive neonatal intensive careother

Neonatal intensive care monitoring and support including ventilatory and inotropic support as clinically indicated

Follow up assessment at 2 years of ageother

The assessment will be carried out using the Bayley Scales of Infant and Toddler Development IV. In addition, all infants will have a detailed neurological examination, including Gross Motor Function Classification System (GMFCS) for cerebral palsy, vision, and hearing assessment. Babies who die or who cannot be assessed with the Bayley-IV due to severe disability will be allocated a Cognitive Scale Composite score one point below the basal test score. PARCA-R will be completed by the parents immediately.